Susquehanna International Group, LLP Voyager Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 33,613 shares of VYGR stock, worth $188,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,613

Previous 56,766 40.79%

Holding current value

$188,232

Previous $449,000 56.35%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $133,592 - $214,628	-23,153 Reduced 40.79%	33,613 $196,000
Q2 2024 Aug 15, 2024	BUY	$7.42 - $10.54 $154,491 - $219,453	20,821 Added 57.92%	56,766 $449,000
Q1 2024 May 07, 2024	SELL	$7.15 - $10.84 $80,180 - $121,559	-11,214 Reduced 23.78%	35,945 $334,000
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $18,764 - $26,324	-2,988 Reduced 5.96%	47,159 $398,000
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $126,228 - $188,088	-16,719 Reduced 25.0%	50,147 $388,000
Q2 2023 Aug 11, 2023	SELL	$6.94 - $13.99 $1.77 Million - $3.57 Million	-254,917 Reduced 79.22%	66,866 $765,000
Q1 2023 May 16, 2023	BUY	$6.0 - $10.78 $1.1 Million - $1.97 Million	182,684 Added 131.33%	321,783 $2.48 Million
Q4 2022 Feb 14, 2023	BUY	$4.94 - $6.61 $352,335 - $471,445	71,323 Added 105.23%	139,099 $848,000
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $156,945 - $210,482	-28,177 Reduced 29.37%	67,776 $401,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $269,732 - $564,646	55,961 Added 139.93%	95,953 $567,000
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $40,320 - $90,598	16,324 Added 68.97%	39,992 $108,000
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $204,953 - $321,067	-77,929 Reduced 76.7%	23,668 $62,000
Q2 2021 Aug 11, 2021	BUY	$3.94 - $5.44 $217,885 - $300,837	55,301 Added 119.45%	101,597 $420,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $39,452 - $77,364	8,558 Added 22.68%	46,296 $218,000
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $116,945 - $200,851	16,356 Added 76.49%	37,738 $270,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $5,515 - $7,576	-551 Reduced 2.51%	21,382 $228,000
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $134,515 - $237,449	-16,710 Reduced 43.24%	21,933 $277,000
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $170,646 - $367,892	25,095 Added 185.23%	38,643 $354,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $51,946 - $68,276	-4,052 Reduced 23.02%	13,548 $189,000
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $140,217 - $243,209	-8,597 Reduced 32.82%	17,600 $303,000
Q2 2019 Aug 16, 2019	BUY	$19.18 - $27.88 $241,476 - $351,009	12,590 Added 92.53%	26,197 $713,000
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $194,726 - $409,175	-22,669 Reduced 62.49%	13,607 $128,000
Q4 2017 Feb 14, 2018	SELL	$12.26 - $25.88 $84,851 - $179,115	-6,921 Reduced 16.02%	36,276 $602,000
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $361,558 - $889,426	43,197	43,197 $889,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $216M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Voyager Therapeutics, Inc. Transaction History